ANIMATION

A Focus on ALK-positive Non-Small Cell Lung Cancer

Share this animation:

In partnership with Wedgewood Communications, XVIVO developed two videos for Takeda Oncology to discuss lung cancer mechanism of disease and treatments.

This animation takes an extensive and detailed look at the sub-populations of patients who have non-small cell lung cancer (NSCLC), which affects about 198,000 new patients in the United States each year.

The animation discussed the variety of possible mutations seen in lung cancer, with a focus on NSCLCs with an ALK mutation. With so many acronyms to be used in the animation, we were challenged to clearly present the lung cancer types and the possible genetic mutations found in the tumor cells.

Share It:
Contact XVIVO

Client


A Focus on ALK-positive Non-Small Cell Lung Cancer

The XVIVO groups combination of scientific and design expertise means their work is unmatched and of a high standard. We were very pleased with the final product and it has been well received by audiences across the globe. We would absolutely recommend working with XVIVO.

Jeremy Moon, CEO Icebreaker
Share this animation: